Skip to main content

CARY STREET PARTNERS INVESTMENT ADVISORY LLC

Position in NVS — Novartis AG

CIK 1766904 RICHMOND, VA

Position in NVS

as of Jun 30, 2026 · filed Jul 17, 2026
Position Value
$377,067
+$24,522 QoQ
Shares Held
2,406
+4.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,013
of 1,603 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $10,872,180 across 13 Drug Manufacturers - General names. NVS ranks #7 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVS
Novartis AG
This page
2,406 $377,067

All Filings in NVS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $377,067 2,406
2026-03-31 $352,545 2,308
2025-12-31 $302,898 2,197
2025-09-30 $246,989 1,926
2025-06-30 $173,769 1,436
2025-03-31 $128,757 1,155
2024-12-31 $29,484 303
2024-09-30 $1,026,321 8,923
2024-06-30 $1,082,696 10,170
2024-03-31 $1,010,633 10,448
2023-12-31 $1,014,343 10,046
2023-09-30 $1,063,111 10,437
2023-06-30 $547,638 5,427
2023-03-31 $648,324 7,047
2022-12-31 $637,126 7,023
2022-09-30 $554,568 7,296
2022-06-30 $553,079 6,543
2021-06-30 $171,257 1,877
2021-03-31 $94,626 1,107
2020-12-31 $300,004 3,177
2020-09-30 $5,342,474 61,436